ThermoFisherScientific - Custom and Bulks
Pharma Focus Europe
Worldwide Clinical Trials - Neuroscience Clinical Development


The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.

XEOMIN® (IncobotulinumtoxinA) Receives Approval for New Therapeutic Use in Switzerland

Saturday, June 15, 2024

Merz Therapeutics a division of the Merz Group specializing in neurotoxins has recently obtained approval from Swissmedic the Swiss Agency for Therapeutic Products for XEOMIN

Biosplice and Novo Nordisk Collaborate on Diabetes Solutions

Friday, June 14, 2024

Biosplice Therapeutics Inc a leader in biotechnology specializes in creating innovative treatments through the use of smallmolecule inhibition targeting DYRKCLK kinases Recently Biosplice has formed a strategic alliance with Novo Nordisk to develop n...

NIIMBL and OAGi Partner to Create Open-Source Ontologies for Biopharmaceutical Manufacturing

Friday, June 14, 2024

The National Institute for Innovation in Manufacturing Biopharmaceuticals has transitioned biopharmaceutical manufacturing ontologies to The Open Applications Group facilitating

Foundation Medicine and Repare Therapeutics Collaborate to Provide Genomic Profiling Services for Clinical Trials and Develop a Companion Diagnostic for Lunresertib

Thursday, June 13, 2024

Foundation Medicine Inc has announced a partnership with Repare Therapeutics a leader in precision

Helsinn Group and Chugai Pharma Europe Renew Their Collaboration to Distribute AKYNZEO® in the UK and Ireland

Thursday, June 13, 2024

Helsinn Group a global pharmaceutical company with over years of experience in supportive care oncology and dermatooncology along with Chugai Pharma Europe Ltd the European subsidiary

Essential Pharma Partners with AGC Biologics for Immunotherapy Production in High-Risk Neuroblastoma Treatment

Wednesday, June 12, 2024

Essential Pharma a global specialty pharmaceutical company has formed a strategic alliance with AGC Biologics a leading contract development and manufacturing organization in the biopharmaceutical

Taiho Oncology Europe Announces the Availability of Lytgobi® (Futibatinib) in Germany for the Treatment of Cholangiocarcinoma.

Wednesday, June 12, 2024

Taiho Oncology Europe GmbH has announced the launch of Lytgobi in Germany following its conditional approval across the European Union Lytgobi is a new oral medication

Dandelion Science and the Wyss Center in Geneva Launch AI Partnership to Innovate Non-Invasive Brain Therapies

Wednesday, June 12, 2024

The Wyss Center for Bio and Neuroengineering in Geneva and Dandelion Science have announced a partnership to develop a cuttingedge generative AI neuromodulation platform This collaboration

Hoth Therapeutics and Wise Systems International SRL Form Alliance to Leverage AI in Drug Discovery

Tuesday, June 11, 2024

Hoth Therapeutics Inc a company dedicated to patientfocused biopharmaceutical solutions announced a new partnership with Wise Systems International SRL This collaboration

Eilean Therapeutics Receives FDA Clearance for IND Application of Lomonitinib in Treating Acute Myeloid Leukemia

Tuesday, June 11, 2024

Eilean Therapeutics LLC is pleased to announce that the US Food and Drug Administration has approved the Investigational New Drug application for lomonitinib This approval allows the company

Thermo Fisher Scientific viral vector services (VVS)ThermoFisher - Mastering API production at every scaleFuture Labs Live - 2024World Orphan Drug Congress 2024World Vaccine Congress Europe 2024Advanced Therapies USA 2024